Susquehanna International Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Susquehanna International Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-43,300	Closed	-$873K	–	14376
2021 Q3	$873K	Buy	43,300 +22,400	+107%	+$618K	﹤0.01%	7924
2021 Q2	$780K	Sell	20,900 -8,800	-30%	-$270K	﹤0.01%	8450
2021 Q1	$759K	Buy	+29,700	New	+$759K	﹤0.01%	8445
2020 Q3	–	Sell	-41,400	Closed	-$1.05M	–	11412
2020 Q2	$1.05M	Buy	+41,400	New	+$892K	﹤0.01%	5809
2020 Q1	–	Sell	-73,400	Closed	-$1.62M	–	11165
2019 Q4	$1.62M	Buy	73,400 +58,500	+393%	+$1.18M	﹤0.01%	4670
2019 Q3	$214K	Buy	14,900 +2,900	+24%	+$41.5K	﹤0.01%	8975
2019 Q2	$189K	Buy	+12,000	New	+$163K	﹤0.01%	9172
2018 Q1	–	Sell	-223,000	Closed	-$2.01M	–	10507
2017 Q4	$2.01M	Buy	+223,000	New	+$1.64M	﹤0.01%	3900

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Susquehanna International Group's DRNA Position: Q4 2021 in Review

Susquehanna International Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 111,005 shares — an estimated $2.24M sold.

Susquehanna International Group first reported a position in DRNA in Q2 2016 and held it in 12 quarters. The position peaked at $5.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Susquehanna International Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Susquehanna International Group sold 111,005 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.24M.
Susquehanna International Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2016 and held it in 12 quarters.
Susquehanna International Group's Dicerna Pharmaceuticals, Inc. position peaked at $5.7M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.